Selective Radioprotection by the Fusion Antioxidant Enzyme GS1XR Via an MMP ‐2/9‐Cleavable Cell‐Penetrating Switch
The FASEB Journal · 30.04.2026 · 40 (8)
DOI: 10.1096/fj.202503666r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 13.04.2026. Verfasst von Huocong He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Radiation Biology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Antioxidants, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Radiation-Protective Agents. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Natural Science Foundation of China, Joint Funds for the Innovation of Science and Technology, Fujian Province, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Radiotherapy is central to cancer treatment but radiation‐induced oxidative stress also damages normal tissues. To achieve selective radioprotection of normal tissues, we systematically evaluated, in vitro and in vivo, the antioxidant and radioprotective performance of a previously engineered fusion antioxidant enzyme, GS1XR (GST–SOD1–X–R9). GS1XR efficiently enters normal cells in low matrix metalloproteinases (MMP)‐2/9 environments, scavenges radiation‐induced reactive oxygen species (ROS), maintains the Nrf2 antioxidant pathway, suppresses apoptosis, and increases clonogenic survival. In contrast, in 3D tumor microenvironments with high MMP‐2/9, cleavage of the X peptide removes R9, resulting in a loss of transmembrane capacity and a pronounced reduction in intracellular ROS scavenging. Animal studies further showed that GS1XR significantly alleviates whole‐body irradiation–induced hematopoietic injury and, in tumor‐bearing models receiving radiotherapy, does not compromise radiotherapy‐mediated tumor control. Collectively, GS1XR couples microenvironment‐responsive cell entry with enzymatic antioxidation to achieve selective radioprotection while preserving radiotherapy‐mediated tumor control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Radiation Biology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
- College of Biological Science and Engineering, Fuzhou University, Fuzhou, Fujian, China.
- The Key Laboratory of Novel Enzyme Design and Creation of Fujian Province, Fuzhou University, Fuzhou, Fujian, China.
ORCID-Profile: Huocong He
Förderung
- Natural Science Foundation of China
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- Natural Science Foundation of Fujian Province
- Fujian Provincial Health Technology Project
- National Natural Science Foundation of China
Zitieren
APA
He, H., Chu, J., Lin, L., Lu, L., Li, C., Han, Y., & Pan, J. (2026). Selective Radioprotection by the Fusion Antioxidant Enzyme GS1XR Via an MMP ‐2/9‐Cleavable Cell‐Penetrating Switch. The FASEB Journal, 40(8). https://doi.org/10.1096/fj.202503666r
Vancouver
He H, Chu J, Lin L, Lu L, Li C, Han Y, et al. Selective Radioprotection by the Fusion Antioxidant Enzyme GS1XR Via an MMP ‐2/9‐Cleavable Cell‐Penetrating Switch. The FASEB Journal. 2026;40(8). doi:10.1096/fj.202503666r
BibTeX
@article{He2026,
author = {He, Huocong and Chu, Jinnan and Lin, Lixiang and Lu, Lulin and Li, Chaoyang and Han, Yanan and Pan, Jianru},
title = {Selective Radioprotection by the Fusion Antioxidant Enzyme GS1XR Via an MMP ‐2/9‐Cleavable Cell‐Penetrating Switch},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {8},
doi = {10.1096/fj.202503666r}
}
EUVIMED